Company Filing History:
3 out of 7 
1 out of 42 
1 out of 1 Years Active: 2013-2015
Title: Catherine Taylor: Innovator in Gene Therapy
Introduction
Catherine Taylor is a prominent inventor based in Trondheim, Norway. She has made significant contributions to the field of gene therapy, holding a total of five patents. Her work focuses on developing pharmaceutical compositions that can effectively treat various conditions through innovative methods.
Latest Patents
Among her latest patents is a composition for use in gene therapy. This invention provides a pharmaceutical composition comprising a nonimmunogenic net polyanionic oligosaccharide, such as an oligouronate, associated with a particulate complex of an anionic nucleic acid material and a cationic macromolecule. This composition may also include at least one pharmaceutical carrier or excipient. Another notable patent involves oligo-guluronate and galacturonate compositions. This invention offers a pharmaceutical composition that includes a macromolecular drug and an oligoguluronate or oligogalacturonate, which can be administered to a mucosal surface in a human or non-human vertebrate subject.
Career Highlights
Catherine has worked with notable organizations such as NTNU Technology Transfer AS and the Norwegian University of Science and Technology. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Catherine has collaborated with esteemed colleagues, including Kurt Ingar Draget and Olav Asmund Smidsrod. These partnerships have further enriched her work and expanded the impact of her inventions.
Conclusion
Catherine Taylor is a trailblazer in the field of gene therapy, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to shape the future of medical treatments and highlight the importance of research in advancing healthcare solutions.